Management of Persistent Bacteremia Caused by Methicillin‐ResistantStaphylococcus aureus:A Survey of Infectious Diseases Consultants
Open Access
- 1 September 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (5) , e42-e45
- https://doi.org/10.1086/506568
Abstract
We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approaching the limit of the susceptible range, most consultants indicated that they would switch to newer antimicrobial agents for treatment.Keywords
This publication has 10 references indexed in Scilit:
- Persistence in Staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcomeScandinavian Journal of Infectious Diseases, 2006
- The Role of Vancomycin in the Treatment ParadigmClinical Infectious Diseases, 2006
- Evidence for Reduction in Breakpoints Used To Determine Vancomycin Susceptibility in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2005
- Staphylococcus aureus EndocarditisJAMA, 2005
- Persistent Bacteremia Due to Methicillin‐ResistantStaphylococcus aureusInfection Is Associated withagrDysfunction and Low‐Level In Vitro Resistance to Thrombin‐Induced Platelet Microbicidal ProteinThe Journal of Infectious Diseases, 2004
- Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin TherapyClinical Infectious Diseases, 2004
- Treatment Outcomes for Serious Infections Caused by Methicillin‐ResistantStaphylococcus aureuswith Reduced Vancomycin SusceptibilityClinical Infectious Diseases, 2004
- Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin‐IntermediateStaphylococcus aureusClinical Infectious Diseases, 2004
- The Emerging Infections Network: A New Venture for the Infectious Diseases Society of AmericaClinical Infectious Diseases, 1997
- Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus EndocarditisAnnals of Internal Medicine, 1991